ClinicalTrials.govpublic full text
CAR2219 CAR-T Cells for the Treatment of R/R B Cell Leukemia and Lymphoma
relapsed or refractory b cell leukemia and lymphoma, car-t, b cell leukemia, b cell lymphoma, cd19/cd22, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 1032395
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.